Literature DB >> 29935298

Investigation of Metal-Catalyzed Antibody Carbonylation With an Improved Protein Carbonylation Assay.

Yi Yang1, Anna Mah2, Inn H Yuk3, Parbir S Grewal3, Abigail Pynn3, Will Cole2, Di Gao2, Fan Zhang4, Jia Chen2, Lynn Gennaro2, Christian Schöneich5.   

Abstract

Protein carbonylation is a posttranslational modification referring to the occurrence of aldehydes and ketones in proteins. The current understanding of how carbonylation, in particular, metal-catalyzed carbonylation, occurs in recombinant mAbs during production and storage is very limited. To facilitate investigations into mAb carbonylation, we developed a protein carbonylation assay with improved assay robustness and precision over the conventional assays. We applied this assay to investigate mAb carbonylation under production, storage, and stress conditions and showed that iron, hydrogen peroxide, and polysorbate 20 at pharmaceutically relevant levels critically influence the extent of mAb carbonylation. In addition, we found that while carbonylation correlates with mAb aggregation in several cases, carbonylation cannot be used as a general indicator for aggregation. Furthermore, we observed that mAb carbonylation level can decrease during storage, which indicates that carbonylation products may not be stable. Finally, we report for the first time a positive correlation between carbonylation and acidic charge heterogeneity of mAbs that underwent metal-catalyzed oxidation. This finding shows that the impact of protein carbonylation on product quality for mAbs is not limited to aggregation but also extends to charge heterogeneity.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lucifer yellow carbohydrazide (LY CH); acidic charge variants; aggregation; charge heterogeneity; metal-catalyzed oxidation; protein carbonylation; quality attributes; recombinant mAb

Mesh:

Substances:

Year:  2018        PMID: 29935298     DOI: 10.1016/j.xphs.2018.06.015

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species.

Authors:  Zephania Kwong Glover; Aaron Wecksler; Baikuntha Aryal; Shrenik Mehta; Melissa Pegues; Wayman Chan; Mari Lehtimaki; Allen Luo; Alavattam Sreedhara; V Ashutosh Rao
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

Review 2.  In silico prediction of post-translational modifications in therapeutic antibodies.

Authors:  Shabdita Vatsa
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.